Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Cash from Financing Activities (2020 - 2025)

Definitive Healthcare (DH) has disclosed Cash from Financing Activities for 6 consecutive years, with -$3.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 70.74% year-over-year to -$3.9 million, compared with a TTM value of -$150.8 million through Dec 2025, down 165.71%, and an annual FY2025 reading of -$150.8 million, down 165.71% over the prior year.
  • Cash from Financing Activities was -$3.9 million for Q4 2025 at Definitive Healthcare, up from -$12.5 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $234.7 million in Q4 2021 and bottomed at -$109.7 million in Q1 2025.
  • Average Cash from Financing Activities over 5 years is $6.2 million, with a median of -$6.4 million recorded in 2022.
  • The sharpest move saw Cash from Financing Activities skyrocketed 8302.62% in 2021, then crashed 538.05% in 2025.
  • Year by year, Cash from Financing Activities stood at $234.7 million in 2021, then tumbled by 104.03% to -$9.5 million in 2022, then soared by 35.9% to -$6.1 million in 2023, then tumbled by 120.52% to -$13.4 million in 2024, then surged by 70.74% to -$3.9 million in 2025.
  • Business Quant data shows Cash from Financing Activities for DH at -$3.9 million in Q4 2025, -$12.5 million in Q3 2025, and -$24.7 million in Q2 2025.